Quick Answer
Prestige Consumer Healthcare Inc. reported Stockholders Equity of $1.83 billion for the year ending 2025.
- Prestige Consumer Healthcare Inc. showed an increase of +10.9% in Stockholders Equity from 2024 to 2025.
- This data is from Prestige Consumer Healthcare Inc.'s annual report (Form 10-K), filed with the SEC on May 9, 2025.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $402.73 million | Q2 2012: $418.33 million | Q3 2012: $438.70 million | Q4 2012: $457.33 million | Q2 2013: $500.31 million | Q3 2013: $541.25 million | Q4 2013: $543.93 million | Q2 2014: $585.81 million | Q3 2014: $594.04 million | Q4 2014: $608.94 million | Q2 2015: $662.72 million | Q3 2015: $685.76 million | Q4 2015: $720.94 million | Q2 2016: $737.48 million | Q3 2016: $774.64 million | Q4 2016: $799.86 million | Q2 2017: $858.55 million | Q3 2017: $895.97 million | Q4 2017: $1.22 billion | Q2 2018: $1.16 billion | Q3 2018: $1.19 billion | Q4 2018: $1.23 billion | Q2 2019: $1.10 billion | Q3 2019: $1.11 billion | Q4 2019: $1.16 billion | Q2 2020: $1.23 billion | Q3 2020: $1.28 billion | Q4 2020: $1.32 billion | Q2 2021: $1.42 billion | Q3 2021: $1.46 billion | Q4 2021: $1.52 billion | Q2 2022: $1.58 billion | Q3 2022: $1.62 billion | Q4 2022: $1.69 billion | Q2 2023: $1.48 billion | Q3 2023: $1.54 billion | Q4 2023: $1.60 billion | Q1 2024: $1.66 billion | Q2 2024: $1.68 billion | Q3 2024: $1.73 billion | Q4 2024: $1.79 billion | Q1 2025: $1.83 billion | Q2 2025: $1.86 billion | Q3 2025: $1.82 billion | Q4 2025: $1.83 billion.
- Over the full 14 years of available data (2012 to 2025), Prestige Consumer Healthcare Inc.'s Stockholders Equity has grown by 355.6%.
- Historical annual values: Fiscal year 2025: $1.83 billion | Fiscal year 2024: $1.66 billion | Fiscal year 2023: $1.45 billion | Fiscal year 2022: $1.58 billion | Fiscal year 2021: $1.36 billion | Fiscal year 2020: $1.17 billion | Fiscal year 2019: $1.10 billion | Fiscal year 2018: $1.18 billion | Fiscal year 2017: $822.55 million | Fiscal year 2016: $744.34 million | Fiscal year 2015: $627.62 million | Fiscal year 2014: $563.36 million | Fiscal year 2013: $477.94 million | Fiscal year 2012: $402.73 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: